[Comment on article: "Neutrophil-to-lymphocyte ratio as a serum biomarker associated with community acquired pneumonia"]

Rev Med Inst Mex Seguro Soc. 2021 Aug 13;59(3):181.
[Article in Spanish]

Abstract
in English, Spanish

Identify in a timely manner, through the neutrophil / lymphocyte index, the severity of patients with pneumonia, including that produced by COVID-19, to improve the surveillance-treatment process towards therapeutic success.

Identificar de manera oportuna, a través del índice neutrófilo/linfocito, la gravedad de los pacientes con neumonía, incluida la producida por la COVID-19, para mejorar el proceso vigilancia-tratamiento hacia un éxito terapéutico.

Keywords: B-Lymphocytes; Coronavirus Infections; Neutrophils; Pneumonia.

Publication types

  • Letter

MeSH terms

  • Biomarkers
  • COVID-19*
  • Humans
  • Lymphocyte Count
  • Lymphocytes
  • Neutrophils
  • Pneumonia* / diagnosis
  • Retrospective Studies
  • SARS-CoV-2

Substances

  • Biomarkers